Dolaut Disposable 8 Medicated Plasters 14mg,Dolaut Monouso 8 Cerotti Medicati 14mg,THERABEL HYENS PHARMA SPA

“ACTIVE ingredients: Piroxicam. Excipients: acrylic copolymer, eudragit E 100; non-woven fabrics, polyester s iliconato.
INDICATIONS: Treatment of conditions of pain and inflammatory nature, rheumatic and between enlargement of joints, muscles, tendons and ligaments.
CONTRAINDICATIONS/EFF.SECONDARY: Hypersensitivity to the active substance (piroxicam) or to any of the excipients; patients in whom substances with a similar mechanism of action (NSAIDs) led to a reaction, pain; ato is contraindicated in patients with peptic ulcer disease in the active phase, in patients with asthma bronchiale, a history of gastrointestinal bleeding from NSAIDs; patients n anticoagulant therapy; pregnancy and breastfeeding; children under the age of 12 years after use, the adhesive plaster should not be used on open wounds or injuries, but only on the skin; Avoid contact with eyes and mucous membranes.
DOSAGE: It is recommended to use only the medicated patch once and replace it every 24 hours for a period not exceeding 8 days. Do not apply two patches on the same day. Medicine from es clu workers on intact skin. After thoroughly rinsing and treating the inflamed area, rub one of the corners between your fingers to remove the protective film and apply the sticky side directly to the skin. In case the product must be applied to joints, the more movements, such as gom and odm of the knee, and it is advisable to use a bandage ritenzi one to apply the joint in a bent position, in order to maintain eight in the house. Do not exceed recommended doses.
STORAGE: This medicine does not require any special conditions for storage.
WARNINGS: Serum levels achieved with beneficial results are essentially lower than those obtained by oral administration, but with strong individual variability, for which the occurrence of systemic side effects, especially at the gastrointestinal level, cannot be excluded. Painkillers, antipyretics, anti-inflammatory drugs or non-steroidal drugs, including piroxicam, can cause hypersensitivity reactions, potentially serious even in subjects not previously exposed to such drugs. These include attacks d’asthma, skin rashes, allergic rhinitis and anaphylactic reactions. The drug should be used with caution in patients with chronic obstructive bronchial diseases, allergic rhinitis or inflammation of the nasal mucosa (nasal polyps), in which asthmatic attacks or inflammatory reactions localized in the skin and mucous membrane (Quincke’s edema) are more frequent. Use with caution in patients with a history of peptic ulcer disease, in patients with a history of trointestinal gas bleeding not secondary to the administration of NSAIDs or other bleeding disorders, in patients with Crohn’s disease or ulcerative ulceros, with severe renal or hepatic dysfunction, or with heart failure. . Long-term use or repeated use of products for skin benefit may result in severe sensitization phenomena. If a hypersensitivity reaction is present, therapy should be discontinued. You should use ela cautiously in the treatment of elderly patients, who tend to be more prepared for adverse events. After a short therapy without results of consuming lt doctor. In order to avoid any phenomena of hypersensitivity or photosensitivity, exposure to direct sunlight should be avoided.
INTERACTIONS: It is unlikely that the use of piroxicam-based patches with other medications. This does not, however, exclude the possibility of competition between piroxicam and other drugs that are absorbed and bind to plasma proteins. Do not use the product together with other oral or topical medications containing piroxicam or three FANS.
SIDE EFFECTS: use of the product may cause local skin reactions such as skin irritation or allergy, such as erythema, itching, burning, contact dermatitis or numbness and tingling at the site of application; with this medicine, cases of injuries, dermatological and extended, and serious, such as urticaria, angioedema, erythema multiforme, have been reported. I know there are no possible reactions of photosensitivity and reactions of the skin and mucous membranes that are more extensive and more serious, including asthma attacks. Systemic reactions following topical use of piroxicam are unlikely to occur; because the plasma levels obtained are lower than those measured after systematic administration, but vary greatly from person to person, cannot exclude, especially in the case of long-term therapy more than the period recommended, and do not look at contraindications and warnings, the appearance of undesirable ati’s effects are systemic, especially at the gastrointestinal level. IN”